Depot Buprenorphine Improves Outcomes in Opioid Dependence
Improvement seen in treatment satisfaction and several secondary end points for depot buprenorphine vs sublingual buprenorphine
Opioid-Related Disorder
Expert Perspective: The Opioid Crisis and COVID-19
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
